Eurofins Advantar Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 50

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Eurofins Advantar General Information

Description

Developer of pharmaceutical drugs. The company engages in research and development of drugs, reformulation of existing drugs, method development and validation for large molecules and small molecules.

Contact Information

Website
www.advantarlabs.com
Formerly Known As
Advantar Laboratories
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 5451 Oberlin Drive
  • Suite 100
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Eurofins Scientific
Corporate Office
  • 5451 Oberlin Drive
  • Suite 100
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eurofins Advantar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eurofins Advantar‘s full profile, request access.

Request a free trial

Eurofins Advantar Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pharmaceutical drugs. The company engages in research and development of drugs, reformulation of existing d
Drug Discovery
San Diego, CA
50 As of 2016

East Rutherford, NJ
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Eurofins Advantar Competitors (12)

One of Eurofins Advantar’s 12 competitors is Cambrex, a Private Equity-Backed company based in East Rutherford, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Private Equity-Backed East Rutherford, NJ
Dermata Formerly VC-backed San Diego, CA
Alcami Private Equity-Backed Wilmington, NC
IriSys (Pharmaceuticals) Formerly VC-backed San Diego, CA
Abeona Therapeutics Corporation Cleveland, OH
You’re viewing 5 of 12 competitors. Get the full list »

Eurofins Advantar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eurofins Advantar FAQs

  • When was Eurofins Advantar founded?

    Eurofins Advantar was founded in 2008.

  • Where is Eurofins Advantar headquartered?

    Eurofins Advantar is headquartered in San Diego, CA.

  • What is the size of Eurofins Advantar?

    Eurofins Advantar has 50 total employees.

  • What industry is Eurofins Advantar in?

    Eurofins Advantar’s primary industry is Drug Discovery.

  • Is Eurofins Advantar a private or public company?

    Eurofins Advantar is a Private company.

  • What is Eurofins Advantar’s current revenue?

    The current revenue for Eurofins Advantar is .

  • Who are Eurofins Advantar’s competitors?

    Cambrex, Dermata, Alcami, IriSys (Pharmaceuticals), and Abeona Therapeutics are some of the 12 competitors of Eurofins Advantar.

  • When was Eurofins Advantar acquired?

    Eurofins Advantar was acquired on 31-Mar-2016.

  • Who acquired Eurofins Advantar?

    Eurofins Advantar was acquired by Eurofins Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »